Education
About Us
Working with TipRanks
Follow Us
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
KRMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.86 - $5.05
Previous CloseN/A
Volume31.78K
Average Volume (3M)144.04K
Market Cap
$122.63M
Enterprise Value$171.15M
Total Cash (Recent Filing)$813.38K
Total Debt (Recent Filing)$689.97K
Price to Earnings (P/E)―
Beta0.75
Next Earnings
May 07, 2025EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding46,102,840
10 Day Avg. Volume84,735
30 Day Avg. Volume144,036
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.40
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.02
Enterprise Value/Ebitda-30.79
Forecast
1Y Price Target
$5.17Price Target Upside88.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
REPRO-MED Systems News
PremiumCompany Announcements
KORU Medical’s CCO Resigns, Interim Leader Appointed
PremiumCompany Announcements
Repro-Med Systems’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
KORU Medical Systems Reports Record 2024 Financial Results
---
Bulls Say, Bears Say
Bulls Say
International GrowthInternational business is expected to grow faster through market share-taking and continued progress.
Product InnovationA new pump paired with an easier-to-use and more patient-friendly infusion set should capture more market share.
Revenue PerformanceRecord quarterly revenue of $8.9M beat consensus by $0.8M, positioning annual revenue at $33.7M, surpassing full-year guidance.
Bears Say
Competitive PressuresThere is wariness of the potential for competitive pressures to expand going forward.
Growth ChallengesGrowth comps are becoming more challenging, and it's unlikely for the U.S. market to accelerate sustainably beyond the high single-digit rate.
Valuation ConcernsValuation is sitting near multi-year highs, causing unease despite potentially higher revenue numbers.
---
Options Prices
Currently, No data available
---
Ownership Overview
17.36% Insiders
5.98% Mutual Funds
28.48% Other Institutional Investors
44.30% Public Companies and
Individual Investors
KRMD FAQ
What was REPRO-MED Systems’s price range in the past 12 months?
REPRO-MED Systems lowest stock price was $1.86 and its highest was $5.05 in the past 12 months.
What is REPRO-MED Systems’s market cap?
REPRO-MED Systems’s market cap is $122.63M.
When is REPRO-MED Systems’s upcoming earnings report date?
REPRO-MED Systems’s upcoming earnings report date is May 07, 2025 which is in 6 days.
How were REPRO-MED Systems’s earnings last quarter?
REPRO-MED Systems released its earnings results on Mar 12, 2025. The company reported -$0.03 earnings per share for the quarter, missing the consensus estimate of -$0.028 by -$0.002.
Is REPRO-MED Systems overvalued?
According to Wall Street analysts REPRO-MED Systems’s price is currently Undervalued.
Does REPRO-MED Systems pay dividends?
REPRO-MED Systems does not currently pay dividends.
What is REPRO-MED Systems’s EPS estimate?
REPRO-MED Systems’s EPS estimate is -0.03.
How many shares outstanding does REPRO-MED Systems have?
REPRO-MED Systems has 46,102,840 shares outstanding.
What happened to REPRO-MED Systems’s price movement after its last earnings report?
REPRO-MED Systems reported an EPS of -$0.03 in its last earnings report, missing expectations of -$0.028. Following the earnings report the stock price went down -17.683%.
Which hedge fund is a major shareholder of REPRO-MED Systems?
Currently, no hedge funds are holding shares in KRMD
---
REPRO-MED Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.17 (88.00% Upside)
$5.17 (88.00% Upside)
Blogger Sentiment
Bullish
KRMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
26.72%
12-Months-Change
Fundamentals
Return on Equity
-32.64%
Trailing 12-Months
Asset Growth
-0.02%
Trailing 12-Months
Company Description
REPRO-MED Systems
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
---
KRMD Company Deck
---
KRMD Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, international expansion success, and progress in novel therapies, contributing to a positive outlook. However, there are challenges in the novel therapies segment's revenue variability and external pressures like tariffs and supply chain issues, which need monitoring.Read More>---
KRMD Stock 12 Month Forecast
Average Price Target
$5.17
▲(88.00% Upside)
Technical Analysis
InfuSystem Holdings
―
Retractable Technologies
―
Utah Medical Products
―
Milestone Scientific
―
Microbot Medical
―
---